1-2 of 2
Christopher FE Pocock, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First Analysis of a Phase II Study of Rituximab-Gemcitabine, Cyclophosphamide, Vincristine and Prednisolone (R-GCVP) for Diffuse Large B Cell Lymphoma (DLBCL) Patients Considered Unsuitable for Anthracycline Containing Chemo-Immunotherapy. An NCRI Lymphoma Clinical Studies Group Trial

Paul Fields, MD, PhD, Andrew Webb, MD, Christopher FE Pocock, MD, PhD, William Townsend, Paul Smith, Amy Kirkwood, Nadjet El-Mehidi, PhD, Peter W Johnson, MD, John Radford, MD, David C Linch, MD FMedSci, David Cunningham, MD
Journal: Blood
Blood (2011) 118 (21): 1634.
https://doi.org/10.1182/blood.V118.21.1634.1634
Published: 2011
Journal Articles

An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicular Lymphoma (Grades 1, 2 and 3a). A Preliminary Analysis

Kirit M Ardeshna, MD, Wendi Qian, Paul Smith, June Warden, Lindsay Stevens, Christopher FE Pocock, MD, PhD, Fiona Miall, MD, David Cunningham, MD, John Davies, MD, Jan Walewski, A. Burhan Ferhanoglu, MD, Ken Bradstock, MB, PhD, David C Linch, MD, FMedSci
Journal: Blood
Blood (2010) 116 (21): 6.
https://doi.org/10.1182/blood.V116.21.6.6
Published: 2010